Stenting "Vulnerable" But Fractional Flow Reserve-Negative Lesions : Potential Statistical Limitations of Ongoing and Future Trials
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..
Can imaging provide sufficient risk stratification to warrant revascularization of a stable plaque with negative fractional flow reserve (FFR)? Prophylactic stenting could at best be applied selectively since the composite group of FFR-negative lesions has a death or myocardial infarction rate of approximately 1%/year or less but modern stents have a rate of 2% to 3.5%/year. Because vulnerable features exist in a minority of lesions, at least 9,000 patients must be screened in order to enroll a cohort with sufficient risk. While several ongoing randomized trials are testing the concept of plaque sealing in FFR-negative lesions, preventive stenting depends on such a small effect that sample sizes to validate or refute its benefit become prohibitive. Since FFR provides a quantitative, straightforward, and reproducible metric of plaque vulnerability and burden without the need for or expense of additional catheter devices, intracoronary imaging cannot meaningfully guide prophylactic stenting when faced with a negative FFR.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
JACC. Cardiovascular interventions - 14(2021), 4 vom: 22. Feb., Seite 461-467 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zimmermann, Frederik M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Fractional flow reserve |
---|
Anmerkungen: |
Date Completed 18.08.2021 Date Revised 18.08.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.jcin.2020.05.036 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321612361 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321612361 | ||
003 | DE-627 | ||
005 | 20231225180221.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jcin.2020.05.036 |2 doi | |
028 | 5 | 2 | |a pubmed24n1072.xml |
035 | |a (DE-627)NLM321612361 | ||
035 | |a (NLM)33602443 | ||
035 | |a (PII)S1936-8798(20)31235-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zimmermann, Frederik M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Stenting "Vulnerable" But Fractional Flow Reserve-Negative Lesions |b Potential Statistical Limitations of Ongoing and Future Trials |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.08.2021 | ||
500 | |a Date Revised 18.08.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Can imaging provide sufficient risk stratification to warrant revascularization of a stable plaque with negative fractional flow reserve (FFR)? Prophylactic stenting could at best be applied selectively since the composite group of FFR-negative lesions has a death or myocardial infarction rate of approximately 1%/year or less but modern stents have a rate of 2% to 3.5%/year. Because vulnerable features exist in a minority of lesions, at least 9,000 patients must be screened in order to enroll a cohort with sufficient risk. While several ongoing randomized trials are testing the concept of plaque sealing in FFR-negative lesions, preventive stenting depends on such a small effect that sample sizes to validate or refute its benefit become prohibitive. Since FFR provides a quantitative, straightforward, and reproducible metric of plaque vulnerability and burden without the need for or expense of additional catheter devices, intracoronary imaging cannot meaningfully guide prophylactic stenting when faced with a negative FFR | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a fractional flow reserve | |
650 | 4 | |a percutaneous coronary intervention | |
650 | 4 | |a vulnerable plaque | |
700 | 1 | |a Pijls, Nico H J |e verfasserin |4 aut | |
700 | 1 | |a Gould, K Lance |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Nils P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JACC. Cardiovascular interventions |d 2008 |g 14(2021), 4 vom: 22. Feb., Seite 461-467 |w (DE-627)NLM186220162 |x 1876-7605 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2021 |g number:4 |g day:22 |g month:02 |g pages:461-467 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcin.2020.05.036 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2021 |e 4 |b 22 |c 02 |h 461-467 |